期刊文献+

白细胞介素-13基因多态性与哮喘易感的关系 被引量:3

Relationship between IL-13 Exon 4 Gene Polymorphisms A2 044G and the Patients with Asthma
下载PDF
导出
摘要 目的:探讨白细胞介素(IL)-13外显子4单核苷酸多态性A2 044G基因与本地区人群哮喘易感性的相关性。方法:采用聚合酶链反应技术(PCR)对36例有明显支气管哮喘家族史的患者和20名健康对照者的IL-13 exon 4基因多态性进行检测,并进行序列测定。结果:正常对照组IL-13 exon 4第2044等位基因为A的频率是18%,为G是82%,支气管哮喘家族史的患者IL-13 exon 4第2044等位基因为A的频率是24%,为G是76%,与测序结果相同,经统计学分析,支气管哮喘组和正常对照组的等位基因频率差异具有统计学意义P<0.05。对照组GG、GA、AA基因型频率分别为66.1%、31.7%和2.1%;哮喘组GG、GA、AA基因型频率分别为60.0%、32.0%和8.0%。结论:IL-13+2044位A/G多态性与支气管哮喘的发病密切相关。 Objective:To study the role of the IL- 13 gene exon 4 A2 044G single nucleiofide polymorphism in the pathogenesis of bronchial asthma. Methods:The IL- 13 exon 4 was amplified by PCR genomic DNA used as templates from 20 healthy persons and 36 patients with dominantly allergic family history living in the local, The PCR products which were sequenced in the end. Results:There was significant difference in the distribution of A/G in IL- 13 exon 2 044, A allele frequency was higher in asthma compared with normal controls P〈0. 05, same as sequencing. GG、GA、AA genotype frequency were 66. 1%、31.7% and 2.1% in controls, respectively; GG、GA、AA genotype frequency were 60.0%、32.0% and 8.0% in asthma, respectively. Conclusion: IL- 13 A2 044G single nucleiotide polymorphism is important in asthmatic mechanism.
出处 《中国临床医学》 北大核心 2007年第3期329-330,共2页 Chinese Journal of Clinical Medicine
关键词 白细胞介素-13 哮喘 等位基因 基因 多态性 Interleukin- 13 Asthma Allele Gene Polymorphism
  • 相关文献

参考文献4

二级参考文献12

  • 1Horsfall AC, Butler DM, Marinova L, et al. Suppression of collagen- induced arthritis by continuous administration of IL-4. J Immumol, 1997, 159: 5687-5696.
  • 2Okada E, Sasaki S, Ishi N, et al. Intranasal immunization of a DNA vaccine with IL-12 and granulocyte-macrophage colonystimulating factor(GMCSF) expressing plasmids in liposomes induces strong mucosal and cell mediated immune against HIV-1antigens. J Immunol, 1997, 159: 3638-3647.
  • 3Holmdahl R, Jansson L, Larsson E, et al. Homologous type Ⅱ collagen induces chronic and progressive arthritis in mice.Arthritis Rheum, 1986, 29: 106-113.
  • 4Lochmuller H, Jani A, Huard J, et al. Emergene of early region 1-containing replication competent adenovirus in stocks of replication-defective adenovirus recombinants during multiple passages in 293 cells. Hum Gene Ther, 1994, 5: 1485-1491.
  • 5Joosten LA, Lubberts E, Durez P, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis; protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum, 1997, 40: 249-260.
  • 6Peleman R, Wu J, Fasgeas C, et al. Recomminant interleukin-4suppresses the production of interferon gamma by human mononuclear cells. J Exp Med, 1989, 170: 1751-1756.
  • 7Allen JB, Wong HL, Costa GL, et al. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4contribute to resolution of experimental arthritis. J Immunol,1993, 151: 4344-4351.
  • 8Lubberts E, Jonosten LA, Chabaud M, et al . IL-4 gene therapy for collagen arthritis suppresses aynovial IL-7 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest, 2000, 105:1697-1710.
  • 9Warfel AH, Thorbecke GJ, Besito DV. Langerhans cells as outposts of the dendritic cell system. Adv Exp Med Biol, 1993, 329:469-480.
  • 10Condon C, Watkins V, Celluzzi CM, et al. DNA-based immunization by in vivo transfectiofi of dendritic cells. Nat Med, 1996, 2:1122-1128.

共引文献7

同被引文献34

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部